Omeros Corporation
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
Last updated:
Abstract:
The present invention relates to MASP-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-3 dependent complement activation.
Status:
Grant
Type:
Utility
Filling date:
31 Jul 2017
Issue date:
5 May 2020